First Heartland Consultants’s Biogen BIIB Stock Holding History

First Heartland Consultants’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-871	Closed	-$247K	–	330
2016 Q4	$247K	Sell	871 -921	-51%	-$273K	0.08%	276
2016 Q3	$561K	Buy	1,792 +215	+14%	+$63.7K	0.16%	156
2016 Q2	$381K	Buy	+1,577	New	+$416K	0.04%	185
2016 Q1	–	Sell	-801	Closed	-$245K	–	277
2015 Q4	$245K	Sell	801 -149	-16%	-$42.8K	0.09%	223
2015 Q3	$277K	Buy	950 +10	+1%	+$3.3K	0.12%	191
2015 Q2	$380K	Buy	+940	New	+$377K	0.1%	172

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

First Heartland Consultants's BIIB Position: Q1 2017 in Review

First Heartland Consultants sold out of Biogen (BIIB) in Q1 2017, closing a stake of 871 shares — an estimated $247K sold.

First Heartland Consultants first reported a position in BIIB in Q2 2015 and held it in 6 quarters. The position peaked at $561K in Q3 2016. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

First Heartland Consultants reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
First Heartland Consultants sold 871 Biogen shares in Q1 2017, an estimated $247K.
First Heartland Consultants first reported a position in Biogen in Q2 2015 and held it in 6 quarters.
First Heartland Consultants's Biogen position peaked at $561K in Q3 2016.
1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on First Heartland Consultants's 13F filing for Q1 2017, filed 12 May 2017.